Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sound Pharmaceuticals Inc. has 1 pending office action currently active. This workload is distributed across 1 distinct examiner, showing no fragmentation in the company's current interactions with the patent office. This focus allows for a direct prosecution path for the pending application.
ROBERT A WAX serves as the busiest examiner for the portfolio with 1 busiest examiner pending action. This individual is responsible for the only pending action currently recorded for the company. Because there is only 1 distinct examiner, the company's immediate patent outcomes are tied to the evaluation of this individual examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WAX, ROBERT A | 1 | 25.0% | +3.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18872701 | EBSELEN CONTAINING ORAL DOSAGE FORMS | WAX, ROBERT A | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18872701 | EBSELEN CONTAINING ORAL DOSAGE FORMS | WAX, ROBERT A | — | §103§112 | Non-Final OA | — | Pending | Dec 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial